Electrophysiologic and hemodynamic effects of slow-channel blocking drugs

Prog Cardiovasc Dis. 1982 Sep-Oct;25(2):103-32. doi: 10.1016/0033-0620(82)90023-8.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Atrioventricular Node / physiology
  • Calcium Channel Blockers / pharmacology*
  • Calcium Channel Blockers / therapeutic use
  • Coronary Circulation
  • Coronary Disease / drug therapy
  • Diltiazem / pharmacology
  • Dogs
  • Electrophysiology
  • Female
  • Heart / drug effects
  • Heart Rate
  • Heart Ventricles / physiopathology
  • Hemodynamics / drug effects*
  • Humans
  • Injections, Intravenous
  • Male
  • Membrane Potentials
  • Myocardial Contraction / drug effects
  • Myocardial Infarction / drug therapy
  • Myocardium / cytology
  • Nifedipine / pharmacology
  • Papillary Muscles / cytology
  • Purkinje Fibers / drug effects
  • Sick Sinus Syndrome / drug therapy
  • Sinoatrial Node / physiology
  • Verapamil / administration & dosage
  • Verapamil / pharmacology

Substances

  • Calcium Channel Blockers
  • Verapamil
  • Diltiazem
  • Nifedipine